AllStripes operates a healthcare technology company. Its technology platform generates deep data insights to accelerate rare disease research and drug development. It allows patients and families to get access to benefits from their own medical data. It was formerly known as ACGTXYZ. The company was founded in 2017 and is based in Livermore, California.
Expert Collections containing AllStripes
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
AllStripes is included in 2 Expert Collections, including Digital Health 150.
Digital Health 150
The most promising digital health startups transforming the healthcare industry
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest AllStripes News
Dec 17, 2021
A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu explained how growing... The post AllStripes: How this HealthTech Company Leverages Science to Advance Rare Disease Research (Pt. 1 & Pt. 2) appeared first on McKesson Ventures.
AllStripes Frequently Asked Questions (FAQ)
When was AllStripes founded?
AllStripes was founded in 2017.
Where is AllStripes's headquarters?
AllStripes's headquarters is located at 220 South Livermore Avenue , Livermore.
What is AllStripes's latest funding round?
AllStripes's latest funding round is Unattributed VC - II.
How much did AllStripes raise?
AllStripes raised a total of $115M.
Who are the investors of AllStripes?
Investors of AllStripes include Lux Capital, Spark Capital, Jazz Venture Partners, Maveron, McKesson Ventures and 10 more.
Who are AllStripes's competitors?
Competitors of AllStripes include Humanscape and 5 more.
Compare AllStripes to Competitors
nference makes biomedical knowledge computable to solve urgent healthcare problems of biopharmas and medical centers. The company offers EMR data, software products and services, record de-identification, curation of unstructured information, and data creation via digitization of pathology and molecular sequencing. It was founded in 2013 and is based in Cambridge, Massachusetts.
Epic specializes in the development of software for healthcare organizations.
Temedica provides insights that enable an end-to-end understanding of patient insights. The company develops indication-specific digital products for use in the fields of acute treatment and health promotion. It offers insights into the fields of pharma, research and development, insurance, and more. Temedica caters to the digital healthcare industry. The company was founded in 2016 and is based in Munich, Germany.
Aetion is a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Neurocast offers a digital biomarker for measuring patients' performance. It helps patients, doctors, and researchers understand the course and cause of neurodegenerative disorders such as Parkinson's disease, Alzheimer’s, and depression. It was founded in 2017 and is based in Amsterdam, Netherlands.
MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.